Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Celgene Corp /de/
Relationship:  
City:   Summit
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   9    
Direct Shares   56,020,938    

Indirect Shares

   6,630,042      
Direct Value   $1,706,961,043    

Indirect Value

   $297,284,323      
Total Shares   62,650,980      
Total Value   $2,004,245,366      


Casi Pharmaceuticals Inc $38,712,500 Epizyme, Inc. $5,401,721 Acceleron Pharma Inc $1,219,912,444 Alliqua BioMedical Inc $19,726,764 Globeimmune Inc $0 Crispr Therapeutics Ag $269,163,337 Jounce Therapeutics Inc $6,498,150 Agios Pharmaceuticals Inc $140,382,410 Sutro Biopharma Inc $7,163,718 Casi Pharmaceuticals Inc $38,712,500 Epizyme, Inc. $5,401,721 Acceleron Pharma Inc $1,219,912,444 Alliqua BioMedical Inc $19,726,764 Globeimmune Inc $0 Crispr Therapeutics Ag $269,163,337 Jounce Therapeutics Inc $6,498,150 Agios Pharmaceuticals Inc $140,382,410 Sutro Biopharma Inc $7,163,718
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Casi Pharmaceuticals Inc CASI 10% Owner 2005-03-31 23,750,000 2005-03-31 0    Premium*  
            Epizyme, Inc. EPZM 10% Owner 2014-02-10 3,674,640 2013-06-05 0    Premium*  
            Acceleron Pharma Inc XLRN 2019-01-18 6,824,685 2013-09-24 0    Premium*  
            Alliqua BioMedical Inc ALQA 10% Owner 2017-04-11 7,342,377 0    Premium*  
            Globeimmune Inc GBIM 10% Owner 2014-07-08 400,670 2014-07-08 600,670    Premium*  
            Crispr Therapeutics Ag CRSP 10% Owner 2016-10-24 4,834,980 2018-11-21 4,173,019    Premium*  
            Jounce Therapeutics Inc JNCE 10% Owner 2017-02-01 3,456,463 2017-02-01 0    Premium*  
            Agios Pharmaceuticals Inc AGIO 10% Owner 2017-04-24 4,010,926 2017-04-24 1,856,353    Premium*  
            Sutro Biopharma Inc STRO 2018-10-01 1,726,197 2018-10-01 0    Premium*  
* Premium Members only  

Records found :    48         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 2
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
CASI Casi Pharmaceuticals Inc 10% Owner   –       –       •   2005-03-31 4 OE $1.50 $10,500,000 D/D 7,000,000 23,750,000 -
EPZM Epizyme, Inc. 10% Owner   –       –       •   2013-06-05 4 A $0.00 $0 D/D 3,267,974 3,267,974 0 -
EPZM Epizyme, Inc. 10% Owner   –       –       •   2013-06-05 4 B $15.00 $999,990 D/D 66,666 3,334,640 2.45 -
XLRN Acceleron Pharma Inc 10% Owner   –       –       •   2013-09-24 4 A $0.00 $0 D/D 57,899 515,774 0 -
XLRN Acceleron Pharma Inc 10% Owner   –       –       •   2013-09-24 4 A $0.00 $0 D/D 2,448,321 2,506,220 0 -
XLRN Acceleron Pharma Inc 10% Owner   –       –       •   2013-09-24 4 B $15.00 $10,000,005 D/D 666,667 3,172,887 2.45 -
ALQA Alliqua BioMedical Inc 10% Owner   –       –       •   2013-11-18 3 IO $0.00 $0 D/D 0 1,672,474 -
XLRN Acceleron Pharma Inc 10% Owner   –       –       •   2014-01-28 4 B $50.00 $15,000,000 D/D 300,000 3,472,887 2.45 -
EPZM Epizyme, Inc. 10% Owner   –       –       •   2014-02-10 4 B $29.25 $9,945,000 D/D 340,000 3,674,640 2.45 -
ALQA Alliqua BioMedical Inc 10% Owner   –       –       •   2014-04-14 4 B $7.00 $5,000,002 D/D 714,286 2,386,760 2.45 -
XLRN Acceleron Pharma Inc 10% Owner   –       –       •   2014-05-05 4 B $42.86 $47,146,000 D/D 1,100,000 4,572,887 2.45 -
GBIM Globeimmune Inc 10% Owner   –       –       •   2014-07-08 4 B $10.00 $2,000,000 I/I 200,000 600,670 1.5 -
GBIM Globeimmune Inc 10% Owner   –       –       •   2014-07-08 4 A $0.00 $0 D/D 400,670 400,670 0 -
ALQA Alliqua BioMedical Inc 10% Owner   –       –       •   2015-05-04 4 B $4.55 $2,999,997 D/D 659,340 3,046,100 2.45 -
XLRN Acceleron Pharma Inc 10% Owner   –       –       •   2016-01-11 4 B $40.00 $32,000,000 D/D 800,000 5,372,887 2.45 -
CRSP Crispr Therapeutics Ag 10% Owner   –       –       •   2016-10-24 4/A B $14.00 $11,202,100 I/I 800,150 4,834,980 1.5 -
CRSP Crispr Therapeutics Ag 10% Owner   –       –       •   2016-10-24 4/A A $0.00 $0 I/I 4,034,830 4,034,830 0 -
CRSP Crispr Therapeutics Ag 10% Owner   –       –       •   2016-10-24 4 B $14.00 $11,202,100 D/D 800,150 4,834,980 2.45 -
CRSP Crispr Therapeutics Ag 10% Owner   –       –       •   2016-10-24 4 A $0.00 $0 D/D 4,034,830 4,034,830 0 -
JNCE Jounce Therapeutics Inc 10% Owner   –       –       •   2017-02-01 4 A $0.00 $0 D/D 2,831,463 2,831,463 0 -
JNCE Jounce Therapeutics Inc 10% Owner   –       –       •   2017-02-01 4 B $16.00 $10,000,000 D/D 625,000 3,456,463 2.45 -
ALQA Alliqua BioMedical Inc 10% Owner   –       –       •   2017-02-27 4 B $0.50 $2,000,000 D/D 4,000,000 7,046,100 2.45 -
ALQA Alliqua BioMedical Inc 10% Owner   –       –       •   2017-04-11 4 A $0.00 $0 D/D 296,277 7,342,377 0 -
AGIO Agios Pharmaceuticals Inc 10% Owner   –       –       •   2017-04-24 4 B $49.50 $30,916,463 I/I 624,575 1,856,353 1.5 -
XLRN Acceleron Pharma Inc 10% Owner   –       –       •   2017-09-25 4 B $37.00 $27,586,904 D/D 745,592 6,118,479 2.45 -
  48  Records found
  1  2      
  Page 1 of 2  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us